Pathology Update September 2025

Hi all,

We’ve done further work since the webinar last week and have added some additional reports:

• Admin Review for non-responders to invites/questionnaires
• Review communication needs to review patients who need messages tailoring to their needs
• Overview reports folder page that pulls together all these categories into one integrated list
• New KPIs to reflect the new setup

We’ve put together a 365 form that you can use to tell us which parts of the system you’re using and how you’d like it to work - https://forms.office.com/e/5dwGYB0sby - please submit one per practice ?

Other resources…

• Video for clinicians on how to use the new pathology templates - https://youtu.be/QWIXZfH1FOk
• Video that provides an overview of the new folder setup and how to use the planner: https://youtu.be/ltnArIjnJdA
• More videos and resources are coming to our channel over the next few days (like & subscribe ?) - Welby Innovate - YouTube
• Recording of the webinar last week - Pathology Changes-20250916_125329UTC-Meeting Recording.mp4
• Link to sign up to follow up webinar on Wednesday 1 October at 1pm - https://events.teams.microsoft.com/event/6906caf0-376b-43c0-811c-905dd57de49a@9e9607b7-90db-4eca-9e7f-e80f2ed8af67
• TPP have allowed practices the option to configure how long links are valid for. We’ve set ours to 28 days instead of the default 7 days. This article explains how to do that, along with some other useful tips to improve communication with patients - How should I configure my system for sending SMS?

While most of the changes we’ve made relate to the reports and templates, we have also used this opportunity to review and make some adjustments to the clinical pathways. Here’s a list of key points…

• BP
  • Coding Hypertension Diagnoses at the point of calculating and recording raised average BPs – previously we coded suspected HTN and waited for the patient to complete further tests, but we have found that’s led to some patients never attending and so not having the diagnosis coded
  • Not loaning BP monitors – we’ve taken this into account much more deliberately, both in our protocols and the messages that can be sent to patients. If you’re using our BP unit and never loan out BP machines, please let us know, and we can configure that for you
  • Eye checks – we’ve added advice to have an eye check to our comms re HTN diagnoses
  • We’ve changed to make more of these messages go via the comms annex rather than a letter that’s attached to a message
• Haematinics
  • B12>1000 – now sent message to check for possible reasons for raised B12. Advise patient to book appt if none identified
  • Folate – now filed even if low and report/protocol for issuing folic acid for 4m if folate < 3
• HbA1c
  • Divided Risk of Hypos (HbA1c<48 and on Insulin/SUs) from patients on other DM meds and HbA1c<42.
• Lipids
  • Rosuva 20 is now being treated as maximum dose, patients on this dose will be offered Ezetimibe as their next line of treatment
  • Patients over 84 won’t be automatically offered statins or dose increases. There’s a new report for clinical review for those who are over 84, on treatment and not on target, to consider titration on an individual basis

We’ve still got some additional help resources to create, but the changes to the main reports are now complete. Thanks for bearing with us through these changes and we hope you find them beneficial.

You can find a copy of the Pathology Planner that was shown during the webinar on the email we sent out. you will be able to download this and use for your own practice.